Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
Australian public assessment report (AusPar) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (302)
2016 (34)
2015 (52)
2014 (32)

Search

Sponsor content

1423 result(s) found, displaying 511 to 520

LAPELGA, NEUTROPEG (Apotex Pty Ltd)

24 July 2019

Prescription medicine registration

Active ingredients: pegfilgrastim.
TERRY WHITE CHEMISTS OLANZAPINE olanzapine 20 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS OLANZAPINE olanzapine 5 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART AMOXYCILLIN AND CLAVULANIC ACID 875mg/125mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS AMOXYCILLIN AND CLAVULANIC ACID 875mg/125mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS PIOGLITAZONE pioglitazone 45 mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS PIOGLITAZONE pioglitazone 30 mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART PIOGLITAZONE pioglitazone 45 mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART PIOGLITAZONE pioglitazone 30 mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART PIOGLITAZONE pioglitazone 15 mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 48
Page 49
Page 50
Page 51
Current page 52
Page 53
Page 54
Page 55
Page 56
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.